Currently, metronidazole is the only drug available to treat trichomoniasis, including resistant cases
Metronidazole desensitization is recommended in patients with trichomoniasis and history of an allergic reaction to metronidazole due to presumed cross reactivity with tinidazole and lack of reliably safe and effective alternative therapies
Tinidazole is used to treat trichomoniasis (a sexually transmitted disease that can affect men and women), giardiasis (an infection of the intestine that can cause diarrhea, gas, and stomach cramps), and amebiasis (an infection of the intestine that can cause diarrhea, gas, and stomach cramps and can spread to other organs
Trichomoniasis is the most common non-viral sexually transmitted infection worldwide and is associated with significant morbidity
In metronidazole refractory trichomoniasis patients, for example, cure rates with tinidazole were as high as 92% (Sobel et al
INTRODUCTION Trichomonas vaginalis is estimated to be the most common non-viral sexually transmitted infection